hohl_mathias Profile Banner
Mathias Hohl Profile
Mathias Hohl

@hohl_mathias

Followers
272
Following
2K
Media
6
Statuses
744

Atrial fibrillation #Afib, #SleepApnea #OSA, #cardiorenal syndrome, #CKD, and the impact of sympathetic neuromodulation by renal denervation. @sfb219, @steelers

Universität des Saarlandes
Joined February 2022
Don't wanna be here? Send us removal request.
@hohl_mathias
Mathias Hohl
3 years
0
15
35
@EricTopol
Eric Topol
3 days
Get this: Coffee suppressed atrial fibrillation! Unexpected results for recurrence from a randomized trial in participants after cardioversion from AF #AHA25 @JAMA_current ☕️ https://t.co/70dPI2R84C
48
436
2K
@drbennisahmed
Ahmed Bennis MD 🫀
1 month
Association between delayed statin initiation after high LDL-cholesterol detection and cardiovascular risk in general health screening examinees Delayed initiation of statins following incidental detection of high LDL-C in general health screenings was associated with a
2
34
122
@annaninii
Anna Nina
1 month
.@AhmadMansour__ sagt es glasklar: Hamas-Terror wird auf deutschen Straßen gefeiert - und der Staat schaut teilweise zu! Seine Diagnose ist vernichtend: "Komplette Bankrotterklärung unserer Demokratie"! Während Juden sich nicht mehr sicher fühlen, dürfen linksextreme Antisemiten
201
1K
7K
@drbennisahmed
Ahmed Bennis MD 🫀
2 months
SGLT2 inhibitors and GLP-1 receptor agonists: impact on mortality in diabetic patients with cardiovascular disease In patients with T2D and ASCVD, treatment with SGLT2-I and GLP-1RA, especially in combination, is associated with a substantial reduction in mortality.
2
29
109
@scottisaacsmd
Scott Isaacs
2 months
Excellent MASLD review for cardiologists highlighting its metabolic nature, links to atherosclerosis, heart failure and atrial fibrillation, the underrecognized role of fibrosis in cardiovascular risk, value of non-invasive tests, and the need for multidisciplinary care.
5
125
399
@dhtomar
Dhanendra Tomar
3 months
We’re hiring a Postdoctoral Fellow! Focus: Mitochondria, Ca²⁺ signaling & protein QC in heart failure. Looking for expertise in iPSC culture, CRISPR gene editing & human organoids. Apply: dhanendra.tomar@wfusm.edu https://t.co/Hvuk39wM9h
0
16
42
@NEJM
NEJM
3 months
Recent meta-analyses showed that metabolic dysfunction–associated fatty liver disease (MAFLD) is associated with an increased risk of new-onset heart failure, atrial fibrillation, chronic kidney disease (CKD), and certain extrahepatic cancers, increasing the risk of each by a
3
169
513
@ChristophBurch
Christoph Burch
3 months
Exercise and the Organ-Brain Axis: Regulation of Neurological Disorders by Emerging Exerkines https://t.co/Vwtc1Wn6ih
3
81
329
@drwilliamwallac
William A. Wallace, Ph.D.
3 months
breaking down how hormones like GLP-1 & ghrelin team up with neural pathways to control hunger & energy balance. https://t.co/flu7xjRcBl
4
55
206
@microbeminded2
Amy Proal, PhD
3 months
Our new review is out! We detail mechanisms by which the viral, bacterial, parasite, and other pathogens that infect humans over a lifetime accelerate features of aging: https://t.co/osEgxokKM7
33
363
1K
@davidasinclair
David Sinclair
3 months
DO‑HEALTH trial: Omega‑3, vitamin D and exercise slowed epigenetic clocks by ~3–4 months over 3 years in those over 70. And lowered invasive cancer risk by 61% https://t.co/TAVugIlTdO
35
196
1K
@NEJM
NEJM
3 months
MASLD has become the most common chronic liver disease worldwide. Giovanni Targher, MD, Luca Valenti, MD (@lucavalenti75), and Christopher D. Byrne, MB, ChB, review the features of the disease as well as pharmacotherapies targeting the associated liver and
4
395
1K
@ChristophBurch
Christoph Burch
3 months
Exercise, the Gut Microbiome and Gastrointestinal Diseases: Therapeutic Impact and Molecular Mechanisms https://t.co/J1w5yWXvAI
52
124
443
@Diabetes_ADA
Diabetes, a research journal of the ADA 🧪
3 months
The GLP-1 Receptor Agonist Dulaglutide Attenuates Hepatic Steatosis in Obesity via a Weight-Independent Mechanism. Read Here➡️ https://t.co/rh7joY3kHj @ADA_Pubs
0
13
38
@rkramann
Rafael Kramann, MD PhD
3 months
Please join us for our 2nd Immuno-Cardiology Symposium in beautiful Bar Harbor, Maine, Sept. 18-19! @jacksonlab @MDIBL explore how dysregulated immune system function contributes to inflammation and fibrosis in disease and related disorders in the kidney, lung and liver
1
9
32
@drbennisahmed
Ahmed Bennis MD 🫀
3 months
Aldosterone and Aldosterone Modulation in Cardio-Kidney Diseases Partial agonists of the MR and directly attenuating aldosterone production using selective aldosterone synthase inhibitors is an emerging approach for patients with HF, CKD, and uncontrolled and resistant arterial
3
49
116
@Markus_Soeder
Markus Söder
3 months
In Bayern gilt Law and Order. Ausländische Straftäter müssen konsequent abgeschoben werden – auch nach Afghanistan und Syrien. Grundsätzlich sollten alle Verbrecher und Schleuser wissen: In Bayern wird man schneller geschnappt und länger verknackt. Insgesamt vollziehen wir bei
599
73
554
@M_Ostermann
Manuel Ostermann
3 months
Was machen @AhmadMansour__, @oliverreporter & ich beim ARD Hauptstadtstudio? Die Auflösung gibt es in ca. 14 Tagen im Podcast „Kaffee, extra schwarz“. Danke für das grandiose Gespräch. https://t.co/o6UBoOez6V
106
74
916
@drbennisahmed
Ahmed Bennis MD 🫀
4 months
Cardiovascular-Kidney-Metabolic Syndrome: A Paradigm for Value-Based Care CKM syndrome represents a unifying framework for the interconnected pathophysiology driving cardiovascular health. Nearly 90% of adults in the United States have CKM syndrome (stage 1 or higher), with more
0
41
66
@MichaelAlbertMD
Michael Albert, MD
3 months
📉 What REALLY happens when you stop anti‑obesity meds? - - - A new meta‑analysis [Wu et al., BMC Medicine, 2025] just mapped the weight regain trajectory after stopping GLP‑1s and other AOMs—and it’s eye‑opening. Key findings: ⏳ First month off: Weight loss continues briefly
14
86
280